Drug Manufacture Most Active: Pacira Pharmaceuticals (NASDAQ:PCRX), Kythera Biopharmaceuticals (NASDAQ:KYTH), KaloBios Pharmaceuticals (NASDAQ:KBIO), Flexion Therapeutics (NASDAQ:FLXN)

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) announced that financial results for the company’s first quarter ended March 31, 2014, will be released before the market opens on Thursday, May 1, 2014. Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) stock opened today at $68.82 and is currently trading at $65.97. The stock showed a positive weekly performance of 6.37%.

KYTHERA Biopharmaceuticals (NASDAQ:KYTH) CEO Keith Leonard unloaded 13,260 shares of KYTHERA Biopharmaceuticals stock on the open market in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $39.08, for a total value of $518,200.80. Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) stock opened at $36.12, in current trading session and currently is at $34.58, by losing -3.66%. The 52 week range of $20.00 – $56.36. Company’s market capitalization is 783.47 million.

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO) Contract revenue decreased $6.1 million in 2013 compared to 2012. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO) stock is currently trading at $2.32. The EPS of the stock is -1.67. Company’s market capitalization is 76.52 million.

Flexion Therapeutics Inc. (NASDAQ:FLXN) Interest income was $0.2 million and $0.2 million for the years ended December 31, 2013 and 2012. Flexion Therapeutics Inc. (NASDAQ:FLXN) stock opened the session at $13.69, and now is at $13.24. The 52 week range of the Flexion Therapeutics Inc. (NASDAQ:FLXN) stock remained $13.00 – $20.85 and the day range was $13.00 – $13.69.